Status:
NOT_YET_RECRUITING
Generalized and Domain-Specific Episodic Thinking for Smoking Cessation
Lead Sponsor:
Virginia Polytechnic Institute and State University
Collaborating Sponsors:
National Cancer Institute (NCI)
Roswell Park Comprehensive Cancer Center
Conditions:
Cigarette Smoking Behavior
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Cigarette smoking remains common, particularly in rural areas, despite ample evidence that smoking causes cancer and respiratory disease. Successful smoking cessation yields the majority of its health...
Detailed Description
Cigarette smoking causes more than a dozen cancers, including cancers of the head and neck, colon, bladder, and lung. Although quitting smoking drastically reduces the risk of cancer mortality, rates ...
Eligibility Criteria
Inclusion
- smoked cigarettes daily for the last 30 days;
- salivary cotinine \> 30 ng/mL, consistent with tobacco use;
- plan to quit smoking in the next 30 days
Exclusion
- prior diagnosis with a smoking-related illness (e.g., respiratory disease);
- past 30-day use any smoking cessation treatment;
- anxiety or mood disorders; and
- medical contraindications for use of nicotine replacement therapy (e.g. pregnancy).
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT07158749
Start Date
January 1 2026
End Date
May 1 2027
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, United States, 24015